Royalty Pharma Plc (RPRX)
50.00
+1.52
(+3.14%)
USD |
NASDAQ |
Apr 17, 16:00
50.18
+0.18
(+0.36%)
After-Hours: 20:00
Royalty Pharma Cash from Investing (Quarterly) : -852.80M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zymeworks, Inc. | 5.097M |
| Johnson & Johnson | -- |
| Revolution Medicines, Inc. | 74.88M |
| Corcept Therapeutics, Inc. | -11.84M |
| Cytokinetics, Inc. | -71.19M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 832.14M |
| Cash from Financing (Quarterly) | -299.60M |
| Free Cash Flow | 897.24M |
| Free Cash Flow Per Share (Quarterly) | 0.2297 |
| Free Cash Flow to Equity (Quarterly) | 94.08M |
| Free Cash Flow to Firm (Quarterly) | 192.63M |
| Free Cash Flow Yield | 3.37% |